Treanda

Type: Product
Name: Treanda
First reported Aug 07 2014 - Updated Aug 07 2014 - 1 reports

Continued solid growth of 36% in New Products - now contributing 27% of revenue

-- New Products on track and reached DKK 1,901 million in revenue driven byAbilify Maintena®, Onfi®, Treanda® and the recent launch of Brintellix®-- US revenue was DKK 1,626 million, an increase of 42% in local currency.Onfi, Sabril® and Xenazine® continue ... [Published EuroInvestor - Aug 07 2014]
Entities: Xenazine, Treanda, Abilify
First reported Jul 31 2014 - Updated Aug 01 2014 - 3 reports

Teva's Q2 Earnings & Revs Grow Y/Y, Updates Outlook

Teva Pharmaceutical Industries Ltd. ( TEVA - Analyst Report ) reported second quarter 2014 earnings of $1.23 per American Depositary Share (ADS), up 2.5% from the year-ago period. The Zacks Consensus Estimate was $1.23.Second quarter revenues grew 2.6% ... [Published Zacks.com - Aug 01 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

More on Teva Q2 results

07:49 ET | About: Teva Pharmaceutical Industries Limited (TEVA)Teva Pharmaceutical Industries (NYSE:TEVA) Q2 results: Total Revenues: $5,045M (+2.5%), Generic Medicine: $2,515M (+4.3%), Specialty Medicine: $2,027M (-1.2%); Operating Income: $1,094M (+14.8%); ... [Published Seeking Alpha - Jul 31 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Severe Liver Damage and Nonallergic Bronchitis with Eosinophilia in a Patient with Follicular Lymphoma Treated with Bendamustine plus Rituximab

ReferencesSwerdlow SH, Campo E, Harris NL: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, ed 4. Lyon, International Agency for Research on Cancer, 2008.National Comprehensive Cancer Network. NCCN guidelines lymphoma, version 1, ... [Published Sexual Development - Jul 22 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 1 reports

Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation with Cephalon, Inc. for its ANDA Bendamustine HCl Powder for IV (Treanda®)

BOCA RATON, Fla., June 23, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for bendamustine hydrochloride powder for IV (infusion), 25 mg/vial and 100 mg/vial, a generic ... [Published PR Newswire: Policy & Public Interest - Jun 23 2014]
First reported May 05 2014 - Updated May 05 2014 - 1 reports

Court Report

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Cephalon Inc. v. Uman Pharma Inc. 1:14-cv-00568; filed April 30, 2014 in the District Court of Delaware Infringement of U.S. Patent Nos. ... [Published Patent Docs - May 05 2014]

More Content

All (11) | News (8) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Continued solid growth of 36% in New Products -... [Published EuroInvestor - Aug 07 2014]
Teva's Q2 Earnings & Revs Grow Y/Y, Updates Out... [Published Zacks.com - Aug 01 2014]
Teva’s 2nd-qtr sales and earnings miss analysts... [Published Pharma Letter - Aug 01 2014]
Teva Pharmaceutical Industries' (TEVA) CEO Erez... [Published Seeking Alpha - Jul 31 2014]
More on Teva Q2 results [Published Seeking Alpha - Jul 31 2014]
Severe Liver Damage and Nonallergic Bronchitis ... [Published Sexual Development - Jul 22 2014]
Breckenridge Pharmaceutical, Inc. Announces Par... [Published PR Newswire: Policy & Public Interest - Jun 23 2014]
Court Report [Published Patent Docs - May 05 2014]
Cephalon files suit against Actavis on generic ... [Published PharmaBiz - Feb 06 2014]
Actavis Confirms Generic Treanda® Patent Challenge [Published PR Newswire: Policy & Public Interest - Feb 04 2014]
Cephalon files patent infringement suit against... [Published PharmaBiz - Dec 31 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Breckenridge Pharmaceutical, Inc. Announces Par... [Published PR Newswire: Policy & Public Interest - Jun 23 2014]
BOCA RATON, Fla., June 23, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for bendamustine hydrochloride powder for IV (infusion), 25 mg/vial and 100 mg/vial, a generic ...
Court Report [Published Patent Docs - May 05 2014]
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Cephalon Inc. v. Uman Pharma Inc. 1:14-cv-00568; filed April 30, 2014 in the District Court of Delaware Infringement of U.S. Patent Nos. ...
Actavis Confirms Generic Treanda® Patent Challenge [Published PR Newswire: Policy & Public Interest - Feb 04 2014]
DUBLIN, Feb. 4, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Bendamustine Hydrochloride for Injection, ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.